Betaseron Videos

Patients treated with Betaseron® interferon beta 1b shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of developing confirmed disability progression compared to patients in whom treatment was delayed. The results—which were fast tracked and ...

Betaseron Video 10Unknown length Jun 9, 2008

Betaseron Video 9Unknown length Jun 9, 2008

Betaseron Video 8Unknown length Jun 9, 2008

Betaseron Video 2Unknown length Jun 9, 2008

Landmark Study in The Lancet: Patients Treated With Betaseron After First MS...Unknown length Apr

Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Significant Delay in MS ProgressionPatients treated with Betaseron interferon beta 1b shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of developing confirmed d...

Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Significant Delay in MS ProgressionPatients treated with Betaseron interferon beta 1b shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of developing confirmed d...

A full video of a Betaseron injection, #159 on 2/09/2008Includes explanation of injection set up and DSC Pride

Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Sign

Video 29192 Landmark Study in The Lancet: Patients Treated With... Lancet, MS, Betaseron, BENEFIT,

I set up my injection #119 on November 21, 2007The injection set up until the requires swishing

I set up my injection #119 on November 21, 2007I throw away my needle, and fumble

I set up my injection #119 on November 21, 2007I load needle into Betaject autoinjector and prep for injection.

I set up my injection #119 on November 21, 2007After swishing, I load the needle. Pause to remove bubbles.

Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Significant Delay in MS ProgressionPatients treated with Betaseron interferon beta 1b shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of developing confirmed d...

Patients treated with Betaseron interferon beta1b shortly after their first clinical MS event or attack showed a 40 percent lower risk of developing confirmed disability progression compared to patients in whom treatment was delayed. The resultswhich were fasttracked and published in The Lancet th

Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Significant Delay in MS Progression Patients treated with Betaseron interferon beta 1b shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of developing confirmed...

Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Significant Delay in MS Progression Patients treated with Betaseron interferon beta 1b shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of developing confirmed d...

Landmark Study in The Lancet: Patients Treated With Betaseron After...MultiVu2 min Aug 3, 2007Land

Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Sign

is a presentation I did for Betaseron regarding my experience with being diagnosed with MS. My Bio: Over the past year Michael has been a patient advocate for Betaseron and has been a proponent of living an active lifestyle with MS. Michael was diagnosed with RRMS i...

Betaseron video32 min Sep 1, 2006Video that was shot to promote BetaSeron featuring information re